Glial fibrillary acidic protein (GFAP) is released from astrocytes into the bloodstream, and its level can be used to distinguish PD from healthy controls,147,148 while its ability to discriminate PD from other atypical parkinsonisms is unclear. This evidence concerns the gene GFAP and Parkinson disease.